C6E 📈 Amundi Index Solutions - - Overview

Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: LU1681040223 • Europe Large-Cap Blend Equity

C6E: European, Stocks, ESG, Index, ETF, Funds

‣ Company URL: https://first-eagle.amundi.com/ ‣ Domicile: Luxembourg ‣ Index Name: Morningstar DM Eur TME NR EUR

Additional Sources for C6E ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

C6E ETF Overview

Market Cap in USD 810m
Category Europe Large-Cap Blend Equity
TER 0.18%
IPO / Inception 2018-04-18

C6E ETF Ratings

Growth 5y 56.0%
Fundamental -
Dividend -
Rel. Strength Industry 146
Analysts -
Fair Price Momentum 114.73 EUR
Fair Price DCF -

C6E Dividends

No Dividends Paid

C6E Growth Ratios

Growth Correlation 3m -47.3%
Growth Correlation 12m 66.7%
Growth Correlation 5y 88%
CAGR 5y 6.37%
CAGR/Mean DD 5y 1.00
Sharpe Ratio 12m 0.41
Alpha -11.56
Beta 0.68
Volatility 15.53%
Current Volume 0.2k
Average Volume 20d 6.7k
What is the price of C6E stocks?
As of December 27, 2024, the stock is trading at EUR 124.25 with a total of 207 shares traded.
Over the past week, the price has changed by -0.41%, over one month by +0.07%, over three months by -4.07% and over the past year by +8.43%.
Is Amundi Index Solutions - a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Amundi Index Solutions - (PA:C6E) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.97 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of C6E as of December 2024 is 114.73. This means that C6E is currently overvalued and has a potential downside of -7.66%.
Is C6E a buy, sell or hold?
Amundi Index Solutions - has no consensus analysts rating.
What are the forecast for C6E stock price target?
According to ValueRays Forecast Model, C6E Amundi Index Solutions - will be worth about 126.3 in December 2025. The stock is currently trading at 124.25. This means that the stock has a potential upside of +1.63%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 126.3 1.6%